STAT3 and ovarian carcinoma: In this study, a combination of CRISPR-Cas9-mediated gene KO and multi-omic genome-wide profiling enabled us to identify multi-level (Bru-Seq, RNA-Seq, and MS Proteomic) expression signatures of parental and STAT3 KO ovarian cancer cells.